530533 Sigma-AldrichTRPV4 Agonist, GSK1016790A - CAS 942206-85-1 - Calbiochem
A cell-permeable, potent, selective agonist of TRPV4 channel. Enhances Ca2+ flux in a variety of human and mouse cells (EC₅₀ = 2.1 nM for human TRPV4).
More>> A cell-permeable, potent, selective agonist of TRPV4 channel. Enhances Ca2+ flux in a variety of human and mouse cells (EC₅₀ = 2.1 nM for human TRPV4). Less<<Synonyms: GSK101, Transient Receptor Potential Vanilloid 4 Channel Agonist
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 942206-85-1 | C₂₈H₃₂Cl₂N₄O₆S₂ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.30533.0001 |
|
Glass bottle | 10 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 942206-85-1 |
| Form | White powder |
| Hill Formula | C₂₈H₃₂Cl₂N₄O₆S₂ |
| Chemical formula | C₂₈H₃₂Cl₂N₄O₆S₂ |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | TRPV4 |
| Purity | ≥98% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 5.30533.0001 | 04055977260854 |
Documentation
TRPV4 Agonist, GSK1016790A - CAS 942206-85-1 - Calbiochem SDS
| Title |
|---|
TRPV4 Agonist, GSK1016790A - CAS 942206-85-1 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 530533 |
References
| Reference overview |
|---|
| OʹConor, C.J., 2014. PNAS. 111, 1316. Sullivan, M.N., et al. 2012. Mol. Pharmacol. 82, 464. Jun, M., et al. 2011. PLoS One. 6, e16713. Thorneloe, K. S., et al. 2008. J. Pharm. Exp. Ther. 326,432. |



